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Abstract
Background: Although macrophages (MW) are known as essential players in wound healing, their contribution to recovery
from spinal cord injury (SCI) is a subject of debate. The difficulties in distinguishing between different MW subpopulations at
the lesion site have further contributed to the controversy and led to the common view of MW as functionally homogenous.
Given the massive accumulation in the injured spinal cord of activated resident microglia, which are the native immune
occupants of the central nervous system (CNS), the recruitment of additional infiltrating monocytes from the peripheral
blood seems puzzling. A key question that remains is whether the infiltrating monocyte-derived MW contribute to repair, or
represent an unavoidable detrimental response. The hypothesis of the current study is that a specific population of
infiltrating monocyte-derived MW is functionally distinct from the inflammatory resident microglia and is essential for
recovery from SCI.
Methods and Findings: We inflicted SCI in adult mice, and tested the effect of infiltrating monocyte-derived MW on the
recovery process. Adoptive transfer experiments and bone marrow chimeras were used to functionally distinguish between
the resident microglia and the infiltrating monocyte-derived MW. We followed the infiltration of the monocyte-derived MW
to the injured site and characterized their spatial distribution and phenotype. Increasing the naı ¨ve monocyte pool by either
adoptive transfer or CNS-specific vaccination resulted in a higher number of spontaneously recruited cells and improved
recovery. Selective ablation of infiltrating monocyte-derived MW following SCI while sparing the resident microglia, using
either antibody-mediated depletion or conditional ablation by diphtheria toxin, impaired recovery. Reconstitution of the
peripheral blood with monocytes resistant to ablation restored the lost motor functions. Importantly, the infiltrating
monocyte-derived MW displayed a local anti-inflammatory beneficial role, which was critically dependent upon their
expression of interleukin 10.
Conclusions: The results of this study attribute a novel anti-inflammatory role to a unique subset of infiltrating monocyte-
derived MW in SCI recovery, which cannot be provided by the activated resident microglia. According to our results, limited
recovery following SCI can be attributed in part to the inadequate, untimely, spontaneous recruitment of monocytes. This
process is amenable to boosting either by active vaccination with a myelin-derived altered peptide ligand, which indicates
involvement of adaptive immunity in monocyte recruitment, or by augmenting the naı ¨ve monocyte pool in the peripheral
blood. Thus, our study sheds new light on the long-held debate regarding the contribution of MW to recovery from CNS
injuries, and has potentially far-reaching therapeutic implications.
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Immune cells play a critical role in the resolution of wound
healing and pathologies that occur in peripheral organs. However,
in the central nervous system (CNS), which is considered an
immune-privileged site, the contribution of these cells to the
healing process remains a subject of controversy [1–14].
Following CNS injury, an intensive local inflammatory response
takes place and involves activated resident microglia, the native
macrophages (MW) of the CNS, and an additional population of
MW that derives from monocytes which infiltrate to the CNS from
the peripheral blood only following the insult [15]; in this study,
we refer to this blood-derived population as monocyte-derived
MW. These two MW populations are indistinguishable by standard
immunohistochemical techniques leading to the common view of
MW as functionally homogenous. The limited spontaneous
recovery, along with the common negative perception of the local
inflammation, have led to the general view of all immune cells at
the lesion site as destructive cells that should be suppressed or
eliminated [1,2,6,7,10,16–19]. Accordingly, research efforts and
clinical manipulations were directed at attempts to overcome this
perceived obstacle to recovery [20], through the use of high-dose
steroids, and by nonspecific MW depletion [1,21]. However, other
studies have demonstrated that ‘‘alternatively activated MW,’’ pre-
incubated ex-vivo with peripheral nerve segments, can induce CNS
repair [22]. Moreover, several independent studies have demon-
strated that MW are capable of secreting neurotrophic factors [23–
25], can promote removal of tissue debris [26,27], and can support
axonal regeneration [28–33].
Outside the CNS, it has recently been recognized that MW
represent a heterogeneous population that can exhibit both pro-
and anti-inflammatory activities [34–37]. Altogether, the apparent
contradictory data regarding the contribution of MW to CNS
recovery, and the recognized heterogeneity of MW outside the
CNS, have led us to suggest that a similar scenario may apply to
the CNS, and that perhaps infiltrating monocyte-derived MW have
a unique role that is not performed by the well-described pro-
inflammatory resident microglia.
Here, we investigated the specific contribution of the monocyte-
derived MW recruited to the damaged tissue.
Methods
Animals
Seven types of mice were used: (1) C57BL/6J mice (n=374 and
another 22 as donors of monocytes); (2) heterozygous mutant
Cx3cr1
GFP/+ mice (B6.129P- Cx3cr1tm1Litt/J, in which one of the
CX3CR1 chemokine receptor alleles is replaced with a gene
encoding GFP [green fluorescent protein] [38]; n=12 as donors of
monocytes, and another eight as donors of bone marrow [BM]);
(3) CD45.1 mice (carrying an allotypic marker, CD45.1; n=8,
another 24 as donors of monocytes, and another three as donors of
BM); (4) Cx3cr1
GFP/+(CD45.1) transgenic mice (carrying both the
Cx3cr1
GFP locus and the allotypic marker, CD45.1; n=8 as donors
of monocytes, and another one as a donor of BM); (5) CD11c-DTR
transgenic mice (B6.FVB-Tg Itgax-DTR/GFP 57Lan/J [39],
carrying a transgene encoding a human diphtheria toxin receptor
[DTR] under control of the murine CD11c promoter; n=10 as
donors of BM); (6) CD11c-DTR: Cx3cr1
GFP/+ transgenic mice
(heterozygous for both the Cx3cr1
GFP locus and the CD11c-DTR
transgene; n=3 as donors of BM); and (7) IL-10 null mice
(B6.129P2-Il10tm1Cgn/J [40]; n=40 as donors of monocytes; a
generous gift from Prof. Irun Cohen, Weizmann Institute of
Science). In each case, adult males aged 8–10 wk were used.
Animals were supplied by the Animal Breeding Center of The
Weizmann Institute of Science. All animals were handled
according to the regulations formulated by the Institutional
Animal Care and Use Committee (IACUC).
BM Radiation Chimeras
[Cx3cr1
GFP/+.wt], [CD11c-DTR.wt], [CD45.1.wt (CD45.2)],
and [CD11c-DTR: Cx3cr1
GFP/+.wt] BM chimeras were prepared
by subjecting gender-matched recipient mice (8–10 wk old) to lethal
whole-body irradiation (950 rad) while shielding the brain, as
previously described [41–43]. Empirically, we found that this
shielding prevented the massive infiltration of myeloid cells to
noninjuredspinalcords(FigureS1A,S1B).FollowingSCI,however,
an intense infiltration of GFP
+ cells was seen in the spinal cord of
these head-shielded chimeras (Figure S1C, S1D). The mice were
then reconstituted with 3–5610
6 BM cells harvested from the hind
limbs (tibia and femur) and forelimbs (humerus) of the appropriate
donor mice. BM cells were obtained by flushing the bones with
Dulbecco’s PBS under aseptic conditions, and then they were
collected and washed by centrifugation (10 min, 1,000 rpm, 4uC).
The extent of chimerismobserved in these chimeras (68.5%62.2%;
[mean6standard error (SE)]) was comparable to that reported
elsewhere [8,44,45]. To rule out the possibility that the observed
homing of monocytes to the injured site of the chimeric mice was
due to any side effect related to the process of the chimerism, the
homing of grafted monocytes to the injured site in chimeric versus
nonchimeric mice was compared; no differences were found (Figure
S1E). Thus, the use of chimeras created with head shielding
preserved the physiological recruitment and homing of MW
following SCI. The chimeric mice were subjected to spinal cord
contusion 8–10 wk after BM transplantation.
Antigens and Vaccination
A MOG-derived altered peptide ligand, MEVGWYRS-
PFDRVVHLYRNGK (MOG-45D) (an analog of pMOG 35–
55), in which aspartic acid is substituted for serine [46], was
prepared by the Peptide Synthesis Unit at the Weizmann Institute.
45D peptide is a weak agonist of the encephalitogenic MOG 35–
55 peptide and does not induce autoimmune disease [46].
Ovalbumin (OVA) peptide was purchased from Sigma-Aldrich
(Rehovot, Israel). Adult mice were vaccinated with 45D or OVA
(100 mg) emulsified in an equal volume of complete Freund’s
adjuvant (CFA; Difco) containing Mycobacterium tuberculosis
(2.5 mg/ml; Difco), as previously described [47,48]. The emulsion
(total volume 0.1 ml) was injected subcutaneously at one site in the
flank, 7 d prior to the spinal cord injury.
Spinal Cord Injury
The spinal cords of deeply anesthetized mice were exposed by
laminectomy at T12, and contusive (200 kdynes) centralized injury
was performed using the Infinite Horizon spinal cord impactor
(Precision Systems), as previously described [47,48] causing
bilateral degeneration without complete penetration of the spinal
cord. The animals were maintained on twice-daily bladder
expression. Animals that were contused in a nonsymmetrical
manner were excluded from the experimental analysis.
Assessment of Functional Recovery from Spinal Cord
Contusion
Recovery was evaluated by hind-limb locomotor performance,
assessed according to the open-field Basso Mouse Scale (BMS)
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(normal mobility); each score represents a distinct motor functional
state. We randomly separated the mice into groups without any
preferences, while verifying that the average starting score was
similar in all groups. Blind scoring ensured that observers were not
aware of the treatment received by each mouse. Locomotor
activity in an open field was monitored twice a week by placing the
mouse for 4 min at the center of a circular enclosure (diameter
90 cm, wall height 7 cm) made of molded plastic with a smooth,
nonslippery floor. Before each evaluation, the mice were carefully
examined for peritoneal infection, wounds in the hind limbs, and
tail and foot autophagia. Animals that showed a difference of more
than 2 score points between their two hind limbs were excluded
from the experimental analysis. The results showing functional
outcomes presented in this study were, in each case, from a single
experiment representative of several independent replicates, as
indicated in the figure legends.
Diphtheria Toxin Administration
Diphtheria toxin (DTx; 8 ng/g body weight; Sigma) was
injected intraperitoneally (IP), repeatedly at 1-d intervals, starting
immediately after the injury, unless described otherwise. The
efficiency of DTx treatment was routinely confirmed both in the
periphery, by assessing the ablation of CD11c
hi cells in the spleen
(Figure S2), and at the lesion site.
MC-21 Administration
MC-21 (an antibody to CCR2) [50] was injected IP starting
immediately after the injury throughout the first week of recovery
(d0, d1, d2, d4, and d6 postinjury).
Adoptive Monocyte Transfer
Gr1
+ monocytes were isolated as previously reported [51].
Briefly, BM cells were harvested from the femora and tibiae of
naı ¨ve mice, and enriched for mononuclear cells on a Ficoll density
gradient. The CD115
+ BM monocyte population was isolated
through MACS enrichment using biotinylated anti-CD115
antibodies and streptavidin-coupled magnetic beads (Miltenyi
Biotec) according to the manufacturers’ protocols. Following this
procedure, monocytes (wt, Cx3cr1
GFP/+ [CD45.1] or IL-10
deficient; purity 90%) were intravenously (IV) injected (3.5610
6
cells per mouse) during the first week of recovery (two or three
injections, as indicated in the figures). This procedure theoretically
enriched the subset of ‘‘Gr1
+ monocytes’’ (commonly recruited to
inflamed tissues) in the peripheral blood by 3-fold, as their total
numbers in the circulation is approximately 10
6 cells.
Immunohistochemistry
Due to technical limitations of some of the antibodies that were
used, two different tissue preparation protocols (paraffin embed-
ded and microtomed frozen sections) were applied, as previously
described [41]. Whenever possible, the results were confirmed
using both techniques. The following antibodies were used: rabbit
anti-GFP (1:100; MBL); rabbit anti- glial fibrillary acidic protein
(GFAP; 1:100; Dako Cytomation), goat anti-IL-10 (1:20; R&D
Systems), mouse anti-arginase I (1:100; BD Biosciences), rat anti-
Ly6C (1:200; Abcam), and hamster anti-CD11c (1:50; Chemicon).
For microglial/ MW labeling, TRITC- or FITC-conjugated
Bandeiraea simplicifolia isolectin B4 (IB-4; 1:50; Sigma-Aldrich) was
added for 1 h to the secondary antibody solution. Secondary
antibodies used included: Cy2-conjugated donkey anti-rabbit
antibody, Cy2/Cy5 conjugated donkey anti-mouse antibody,
Cy3-conjugated donkey anti-mouse, Cy3-conjugated donkey
anti-goat, and biotin goat anti-hamster (1:200; all from Jackson
Immuno Research). Cy3-streptavidin was used for CD11c
staining. The slides were exposed to Hoechst stain (1:4,000;
Invitrogen Probes) for 1 min.
Myelin integrity was qualitatively examined on paraffin-
embedded sections that were stained with Luxol fast blue for
myelin, and with Nissl to identify the nuclei and the thin
cytoplasmic layer around them. GFAP staining was used for
demarcation of the lesion site.
Isolation of Spinal Cord Cells and Flow Cytometric
Analysis
Mice subjected to spinal cord injury were killed by an overdose
of anaesthetic and their spinal cords were prepared for flow
cytometric analysis by perfusion with PBS via the left ventricle.
Spinal cord sections were cut from individual mice, including the
injured site and adjacent margins, or an area distal to it (4 mm
long in each of the sections), and tissues were homogenized using a
software controlled sealed homogenization system (Dispomix;
http://www.biocellisolation.com). The following fluorochrome-
labeled monoclonal antibodies were purchased from BD Pharmin-
gen, BioLegend, or eBioscience and used according to the
manufacturers’ protocols: PE conjugated anti-CD11c, MHCII,
Gr1(Ly6C), CD34, Mac3, CD11b, CD31, CD4, TCRb, and
CD115 antibodies; allophycocyanin-conjugated anti-CD45.1, Gr1
(Ly6C/G), and CD8 antibodies; AlexaFluor anti-CD19 antibod-
ies; PerCP-conjugated anti-CD11b antibody; and biotin-conjugat-
ed anti-CD115 antibody. Cells were analyzed on a FACSCalibur
cytometer (BD Biosciences) using CellQuest software (BD
Biosciences). Isotype controls were routinely used in all the
experiments. In addition, in each experiment, relevant negative
control groups were used to determine the populations of interest
and to exclude others.
Data Quantification
For microscopic analysis, a Nikon fluorescent microscope (Nikon
E800) or Zeiss LSM 510 confocal laser scanning microscope were
used. Longitudinal sections of the spinal cord were analyzed.
Numbers of cells, immunoreactivity (density) and lesion size were
determined automatically with Image-Pro Plus 4.5 software (Media
Cybernetics). For quantification of number of cells, a unique
quantification method was used, based on Image-Pro software, that
takes into consideration the accumulation of cells in clusters.
Manual quantification and flow-cytometric analysis were also
performed to verify the results provided by the automated analysis.
In order to avoid overestimation due to counting of partial cells that
appeared within the section, we took special care to count only cells
with intact morphology and a nucleus that was larger than 4 mmi n
diameter, both in the manual and software-automated counting.
Throughout the study, the area counted was 1–2 mm
2.T h e
numberofcellspermm
3 wascalculatedbyconsideringthethickness
of the sections. For quantification based on FACS analysis (n=4–6
mice per group), positive events were counted in 25% of the sample,
except for the adoptive transfer experiments in which the entire
sample was analyzed.
Statistical Analysis
Data were analyzed using the Student’s t-test to compare between
two groups. One-way or two-way ANOVA was used to compare
several groups; the Tukey’s HSD procedure (p=0.05) was used for
follow-up pairwise comparison of groups. Repeated measures
ANOVA was used in the functional BMS scoring with follow-up
comparison of treatments for each day by contrast t-test and
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The specific tests used to analyze each set of experiments are
indicated in the figure legends. The results are presented as
mean6SE. In the graphs, y-axis error bars represent SE.
Results
Macrophages Derived from Infiltrating Monocytes Are
Recruited to the Margins of the Lesion Site Following
Spinal Cord Injury
As circulating precursor cells, monocytes are well known to
infiltrate sites of injury outside of and within the CNS [9,36,37].
To test their involvement in the recovery from SCI, we first
performed an adoptive transfer of labeled naı ¨ve monocytes to
investigate features of their recruitment and fate. The monocyte
graft was isolated from Cx3cr1
GFP/+ mice [38] (C57BL/6, CD45.1)
that carry a genetic reporter gene label (Cx3cr1
GFP/+) and an
allotypic marker (CD45.1), allowing detection of graft-derived cells
in the recipient animals (C57BL/6, CD45.2) by immunohisto-
chemistry and by flow cytometric analysis, respectively. Wild type
(wt) C57BL/6 mice were subjected to a severe, well-calibrated
contusive SCI at the level of T-12 [47]. Following injury, the
animals were injected intravenously with labeled naı ¨ve monocytes
(Cx3cr1
GFP/+/CD45.1
+). As we did not yet know the time frame
following injury at which the monocyte-derived MW infiltrate the
CNS, and whether and when they are needed, we repeatedly
injected naı ¨ve monocytes (3.5610
6 cells) during the first week after
the injury (d0, d3 postinjury), thereby trying to ensure continuous
and stable elevated levels of graft-derived naı ¨ve monocytes in the
blood. This procedure theoretically enriches the subset of ‘‘Gr1
+
monocytes’’ (commonly recruited to inflamed tissues) in the
peripheral blood by 3-fold, as their numbers in the circulation is
approximately 10
6 cells.
Flow cytometric and histological analysis 7 d after transfer
revealed the presence of labeled injected cells (GFP
+, CD45.1
+)a t
the lesion site, but not distal to it (Figure 1A–1C). Interestingly,
these GFP
+ monocyte-derived MW were concentrated at the
margins of the lesion, but were absent from the epicenter
(Figure 1C).
We next examined whether the augmentation of the physio-
logical pool of naı ¨ve monocytes in the peripheral blood following
SCI, by adoptive transfer of naı ¨ve monocytes, could enhance
motor function recovery beyond the spontaneous level. Recovery
of motor function was evaluated using a scale for hind limb motor
ability in an open field (BMS [49]), in which a score of 0 indicates
complete paralysis, and a score of 9 represents complete mobility.
The augmentation of the monocyte pool resulted in recovery that
exceeded the spontaneous recovery levels (Figure 1D, 1E; BMS
score [mean6SE]: 4.560.4 and 3.060.1, respectively). These
results suggested that monocytes can home from the peripheral
blood to the margins of the lesion site following injury, and that
increasing their numbers leads to improved recovery. However,
these results were not sufficient to determine when the monocytes
are needed, why this improved recovery does not occur
spontaneously, and what the unique role of the monocyte-derived
MW is that could not be provided by the resident microglia pre-
existing in the injured site. To address these questions, we could
not use this experimental paradigm of adoptive transfer of labeled
monocytes to spinally injured wt mice; while the graft-derived MW
could be discriminated from activated microglia according to their
label (Figure 1), unlabeled infiltrating endogenous host monocyte-
derived MW are indistinguishable from the resident microglia by
standard immunohistochemical techniques. Thus, to differentiate
between the resident activated microglia and the endogenously
infiltrating monocyte-derived MW, we used an established BM
chimera approach based on the unique radioresistance of resident
microglia [9,15,26]. CX3CR1 is expressed on monocyte-derived
MW and resident microglia, and therefore, in transgenic mice that
carry a GFP gene under the control of the CX3CR1 promoter, both
of these populations are labeled [38,52,53]. However, in
[Cx3cr1
GFP/+.wt] BM chimeras, whose wt BM was replaced with
Cx3cr1
GFP/+ BM, the GFP-label is restricted to monocytes, thereby
enabling infiltrating monocyte-derived MW to be distinguished
from resident microglia [9]. Notably, preparation of the chimeras
Figure 1. Monocyte-derived macrophages, spontaneously recruited to the injured spinal cord following the injury, promote
functional recovery. Wild-type mice were subjected to SCI and received passive transfer (injected intravenously) of monocytes (CD45.1
+ or
Cx3cr1
GFP) during the first week of recovery. (A–C) Spinal cords were excised 7 d after the injury and analyzed for the presence of infiltrating
monocyte-derived MW. Flow cytometric analysis of (A) lesion area (4 mm segment) of injured spinal cord from mice treated with and without (w/o)
adoptive transfer of monocytes (CD45.1
+/CD11b
+), indicating the arrival of graft-derived MW to the lesion area. (B) Flow cytometric analysis of lesion
and distal areas (4 mm segment each) from injured spinal cords of adoptively transferred mice indicating the accumulation of the graft-derived MW
(CD45.1
+/CD11b
+) mainly at the lesion and not at the distal areas (2,2596431 engrafted cells per gram of tissue taken from lesion area [mean6SE]).
(C) Immunohistochemical analysis showing the adoptively transferred cells (Cx3cr1
GFP/+; green) restricted to the margins of the lesion site, delineated
by GFAP expression (red, right frame) (scale bar=100 mm). (D) Similarly treated animals were followed for locomotor activity assessed according to
the BMS (repeated measures ANOVA; F[between groups]1,18=16.7; p=0.0007). y-Axis error bar represents SE. (E) Mean locomotor score (BMS) of
individual mice on d28 after spinal cord injury (Student’s t-test; t=25.09; df=15; p=0.0001), suggesting that increasing the pool of naı ¨ve monocytes
by IV injection of wt mice following SCI enhanced recovery beyond spontaneous levels. The assessment of the functional outcome presented here is
from one experiment representative of three independent experiments performed.
doi:10.1371/journal.pmed.1000113.g001
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cell recruitment to the CNS [8,9]. Indeed, we observed in
[Cx3cr1
GFP/+.wt] BM chimeras monocyte infiltration to both the
brain (Butovsky et al., personal communication) and spinal cord,
even in the absence of any injury (Figure S1A, S1B). Therefore, all
the chimeric mice that were used in our study were prepared in a
way that prevents irradiation-induced monocyte infiltration to the
spinal cord in the absent of an insult (see Methods).
Following the SCI, both resident microglia and the infiltrating
monocyte-derived MW expressed the activation marker IB-4 (IB-
4
+/GFP
2 versus IB-4
+/GFP
+ cells, respectively) (Figure 2A).
Importantly, the spatial distribution of the infiltrating endogenous
monocyte-derived MW in the parenchyma of the injured spinal
cord of the chimeric mice was similar to that seen following the
passive transfer of monocytes to nonchimeric injured mice
(Figure 1C); monocyte-derived MW were restricted to the margins
of the lesion site (demarcated by GFAP expression) and excluded
from the epicenter (Figure 2A, 2B). These results supported the
concept, demonstrated above (Figure S1), that the infiltration of
monocyte-derived MW to the injured spinal cord in the chimeric
mice is a physiological phenomenon, and enabled us to use this
model for further investigation of the monocyte-derived MW
distribution and contribution. Notably, monocyte-derived MW
localization to the margins of the lesion appeared to be
independent of the lesion severity (Figure S3). In addition, the
chimeric mice enabled us to determine the spatial distribution of
the resident microglia. Thus, the activated resident microglia (IB-
4
+/GFP
2), unlike the infiltrating monocyte-derived MW, were
Figure 2. Monocyte-derived macrophages acquire a unique phenotype in close proximity to the lesion site. Chimeric mice were
subjected to SCI and analyzed a week later for homing of cells. (A) Cells labeled for IB-4 (red), and GFP (green) at the lesion site of [Cx3cr1
GFP/+.wt] BM
chimeric mice. (B) Cells labeled for GFAP (red) and GFP (green), demonstrating that the infiltrating myeloid cells barely penetrate the lesion epicenter.
(C) Representative flow cytometric analysis showing the extent of expression of various markers by the infiltrating myeloid cells (CD11b
+/ Cx3cr1
GFP/+/
CD45.1
+) in the injured spinal cords of [Cx3cr1
GFP/+ (CD45.1).wt (CD45.2)] BM chimeras. The numbers above the bars refer to the percentage of the
cells positive for the indicated marker out of the R16R2 population (representing the infiltrating monocytes). The bars point to cells positive for the
indicated marker (isotype control, gray line). (D) Spatial distribution map of monocyte-derived MW (GFP
+) at specific distances relative to the
epicenter of the lesion site in [Cx3cr1
GFP/+.wt] BM chimeras based on immunohistochemical analysis. (E) High magnification of GFP
+ cells (green)
from distal and marginal areas of the lesion, demonstrating morphological differences. (F) Representative confocal micrograph of longitudinal
sections from injured spinal cord of [Cx3cr1
GFP/+.wt] BM chimeras, labeled for Ly6C (red), and infiltrating monocyte-derived MW by GFP (green).
Lower panel: z-axis projection of a single cell. (G) Representative confocal micrograph of longitudinal sections of injured spinal cord, labeled for
monocyte-derived MW by GFP (green) and CD11c (red). Lower panel: z-axis projection of single cell. (H) Flow cytometric analysis of distal and lesion
spinal cord samples for CD11c expression on MW (CD11b+ cells) in [Cx3cr1
GFP/+(CD45.1).wt(CD45.2)] BM chimeras. Note the higher incidence of
CD11c
high cells in the lesion sample. The histogram to the right is gated on CD11b
+/CD11c
high cells at the lesion area, showing that both resident
(CD45.1
2) and infiltrating (CD45.1
+) cells express CD11c. The dashed line demarcates the lesion site in (A), (B), (F), and (G), as determined by GFAP
immunoreactivity. Scale bar in (B) and (G), represents 250 mm; in (A) and (F), 100 mm; in (E), and lower panels of (F) and (G), 10 mm. Five mice were
analyzed in each group.
doi:10.1371/journal.pmed.1000113.g002
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margins (Figure 2A).
To gain further insight to the features of the infiltrating cells, we
performed a comprehensive flow cytometric analysis. Because of
the scarcity of the infiltrating cells, we adopted a new protocol that
enabled efficient collection of the cells (see Methods for details).
The bulk of infiltrating cells represented myeloid cells expressing
CD11b, CD115, F4/80, Mac3, and Gr1 (Figure 2C), but lacking
lymphoid or progenitor markers (Figure S4). Moreover, the cells
displayed activation markers [54] including CD11a, CD11c, and
MHC II (Figure 2C). Based on immunohistochemical analysis, we
found that most of the GFP
+ infiltrating cells were concentrated
within the margins of the lesion (Figure 2D). These marginal
infiltrating monocyte-derived MW acquired an activated morphol-
ogy manifested by a large cell body with almost no processes,
whereas the distal infiltrating cells demonstrated a multi-process
morphology with a small cell body (Figure 2E). Notably, the
infiltrating cells at the margins were Gr1
+(Ly6C
+), whereas the
distal ones were Gr1
2 (Ly6C
2) (Figure 2F). Moreover, monocyte-
derived MW at the margins of the lesion, unlike infiltrating cells
(GFP
+) distal to it, expressed CD11c (Figure 2G), a b-integrin
expressed by activated MW at inflammatory lesions in the spinal
cord [55]. Flow cytometric analysis of dissected spinal cord tissues
confirmed the expression of CD11c by MW (CD11b
+), including
both infiltrating MW (CD45.1
+) and activated resident microglia
(CD45.1
2), at the lesion area, but not distal to it (Figure 2H).
However, the localization of the CD11c
+ microglia changed as
recovery progressed; at early time points, CD11c expressing
microglia were confined to the margins (Figure 2G), whereas later
(from d14 onward) these cells were also found at the epicenter of
the lesion (Figure S5).
Macrophages Derived from Infiltrating Monocytes Are
Involved in the Process of Recovery from Spinal Cord
Injury
We next wished to investigate the role of these infiltrating cells
in functional recovery. Since the spontaneously recruited mono-
cyte-derived MW, located at the margins of the lesion site,
expressed CD11c, we implemented a conditional in vivo cell
ablation strategy targeting cells by virtue of their CD11c promoter
activity. Specifically, we generated [CD11c-DTR: Cx3cr1
GFP/+
.wt] BM chimeras whose wt BM was replaced by BM of mice
that carry both the GFP insertion in the Cx3cr1 locus, and a DTR
transgene under control of the CD11c promoter [39]. In the
resulting mice, GFP expression could be used to trace the CNS
infiltrates, and administration of DTx allowed the elimination of
only the infiltrating monocyte-derived MW that expressed CD11c
while sparing CD11c
+ resident microglia. [CD11c-DTR:
Cx3cr1
GFP/+.wt] BM chimeras were subjected to the SCI protocol
2 mo after BM transplantation. The DTx was given immediately
following the injury every other day to ensure depletion of all BM-
derived cells that could be potentially recruited to the injury site.
We confirmed that DTx treatment resulted in specific depletion of
infiltrating monocyte-derived cells (CD11c
+) at the injured cord
(Figure 3A, 3B), but spared the resident CD11c
+ microglia (GFP
2)
(Figure 3C). To assess recovery in the absence of CD11c
+
monocyte-derived MW, we performed a similar experiment in
which half of the mice received serial IP injections of DTx during
the entire recovery period. Although under our experimental
conditions of severe SCI spontaneous recovery was very limited,
treatment with DTx further diminished this limited recovery of
hind limb motor function (Figure 3D, 3E). As a corollary,
depletion of the monocyte-derived MW resulted in a greater spread
of damage, manifested by larger lesion size as determined by
Luxol-Nissl staining (Figure 3F, 3G). Taken together, the results
presented in Figure 1, showing that increasing the peripheral pool
of naı ¨ve monocytes enhanced recovery, with the impaired
spontaneous recovery following depletion of CD11c-expressing
MW derived from infiltrating peripheral monocytes, suggest that
CD11c
+ descendants of spontaneously infiltrating monocytes
contribute to the recovery process following SCI. These findings
raised the further question as to why the spontaneous recovery is
limited: is it due to the suboptimal number, to timing, or to activity
of the infiltrating monocyte-derived MW?
Vaccination Augments Spontaneous Monocyte
Infiltration to the Injured Spinal Cord
To address the factors involved in the limited spontaneous
recovery, we chose an experimental paradigm involving T cell–
based vaccination with a myelin-derived peptide, which has been
shown to significantly enhance recovery from SCI, while avoiding
the induction of experimental autoimmune encephalomyelitis
[46,56,57]; this vaccination procedure is associated with the
activation of microglia/MW at the injured site [47,48,58,59]. We
hypothesized that this vaccination protocol (using MOG-derived
altered peptide [35–55; MOG-45D]) might affect monocyte
infiltration, and thus would allow us to test whether one of the
limiting factors in the spontaneous recovery is related to the
process of monocyte-derived MW recruitment. To that end, we
analyzed infiltration of monocytes in spinally injured chimeric
mice that were vaccinated 1 wk before the injury. The analysis of
SCI lesions of [Cx3cr1
GFP/+.wt] BM chimeras revealed that the
number of IB-4
+ cells increased during the period of assessment in
both the vaccinated and untreated mice (Figure 4A). Analysis for
the presence of the GFP
+ cellular infiltrate revealed that from d4
onward, there was a higher level of monocyte-derived MW in the
immunized group compared to the control (Figure 4B, 4C). The
effect of the vaccination on monocyte-derived MW recruitment
was confirmed by flow cytometric analysis of [CD45.1.CD45.2]
BM chimeras (1,6986361 versus 3,0466471 CD45.1
+/CD11b
+
infiltrating cells/mg tissue [mean6SE], in control and vaccinated
groups respectively; Student’s t-test p,0.05). Furthermore, the
vaccination not only increased the total number of infiltrating
monocyte-derived MW but also the abundance of these cells that
expressed CD11c (Figure 4D). In accordance with the previously
reported effects on recovery [47,48], the enhanced monocyte-
derived MW recruitment was specific for vaccination with a CNS-
related antigen (45D), and was not seen following immunization
with an irrelevant antigen (OVA), or challenge with CFA or PBS
alone (Figure S6).
Enhanced Recovery, Achieved by Vaccination, Is
Dependent on Augmentation of Spontaneous Monocyte
Infiltration to the Injured Spinal Cord
Having demonstrated that vaccination induced earlier and
augmented infiltration to the injured spinal cord of monocyte-
derived MW expressing CD11c, we next used this paradigm to test
whether this earlier increase of infiltration could be responsible for
the observed enhanced recovery. We therefore adopted again the
conditional in vivo cell ablation strategy, targeting cells by virtue of
CD11c promoter activity. We vaccinated [CD11c-DTR: Cx3cr1
GFP/+
.wt] BM chimeric mice and 1 wk later subjected all mice to SCI.
The animals were then separated into two groups (see Methods for
details); one group received treatment with DTx along the entire
recovery period and one group remained untreated. The efficiency
of the ablation and its specificity for CD11c
+/GFP
+ monocyte-
derived MW, but not activated CD11c
+/GFP
2 microglia, were
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+/
GFP
+ cells out of CD11b
+ cells without versus with DTx treatment,
respectively) and histology (Figure S7A). The specific depletion of
the CD11c
+/GFP
+ monocyte-derived MW resulted in increased
numbers of CD11c
+ resident microglia (Figure 5A; 4.6% versus
8.5% CD11c
+/GFP
2 cells out of CD11b
+ cells without versus with
DTx treatment, respectively), suggesting that the infiltrating
monocyte-derived MW regulated activated resident microglia. We
did not observe any significant effect on other inflammatory cell
populations by the DTx treatment (Figure S7B, S7C). Importantly,
in accordance with our previous studies, the vaccination resulted in
enhanced recovery (Figure 3D, dark blue, versus Figure 5B, green),
which was completely abrogated when the activated monocyte-
derived CD11c
+ MW were ablated (Figure 5B, 5C). To substantiate
the functional BMS results, we analyzed the size of the lesions 21
days after injury by Luxol-Nissl staining. Spinal cords of vaccinated,
DTx-treated mice showed significantly enlarged lesions as com-
pared to injured chimeric controls (Figure 5D, 5E). Interestingly,
impairment of recovery was evident earlier in the vaccinated mice
than in animals that were allowed to recover spontaneously
(Figure 5B versus Figure 3D), in correlation with the earlier
monocyte infiltration and appearance of CD11c
+/GFP
+ cells in
close proximity to the injury site (Figure 4B, 4D). Notably, the
vaccinated mice showed improvement in motor function similar to
that of the wt mice that were adoptively transferred with naı ¨ve
monocytes (Figure 1D, 1E). To exclude a general toxic effect of the
DTx that could directly cause a decline in motor function, we
repeated the experiment using wt C57BL/6J mice that are resistant
to DTx. Repeated injections of DTx starting immediately after SCI
had no effect on functional motor recovery in these animals (Figure
S8), supporting the reliability and specificity of this ablation
procedure. The fact that both recovery and monocyte recruitment
were augmented using the vaccination paradigm encouraged us to
use this paradigm as a more sensitive system to further study the
involvement of infiltrating monocytes in the recovery process.
Therefore, MOG-45D vaccination was used in all further
experiments.
To provide additional independent evidence for the critical role
of infiltrating monocyte-derived MW in the recovery from SCI, we
took advantage of the anti-CCR2 antibody MC-21, which
Figure 3. Infiltrating monocyte-derived macrophages are involved in the spontaneous process of functional recovery from spinal
cord injury. [CD11c-DTR: Cx3cr1
GFP/+.wt] BM chimeras were generated by reconstitution of irradiated C57BL/6J mice with CD11c-DTR: Cx3cr1
GFP/+
BM. All mice were subjected to SCI, and half of them received IP injections of DTx starting immediately after the injury, then every other day. (A) GFP
staining of the injury site to detect the presence of monocyte-derived MW, without (w/o; left panel) or with (right panel) DTx ablation (scale
bar=250 mm). (B) Quantitative analysis of monocyte-derived MW (number of GFP
+ cells) at the injured site. Treatment with DTx significantly reduced
the number of monocyte-derived MW (Student’s t-test; t=27.39; df=5; p=0.0007). (C) Representative micrograph of injured spinal cord sections,
labeled for monocyte-derived MW by GFP (green) and for CD11c (red). The sections were taken from DTx-treated animals, showing that the remaining
GFP
+ cells following ablation are CD11c negative, whereas the remaining CD11c
+ cells are GFP
2, representing the resident microglia (scale
bar=100 mm). (D) Hind-limb locomotor performance was assessed according to the BMS (repeated measures ANOVA; F[between groups]1,15=4.88;
p=0.04). (E) Mean locomotor score (BMS) of individual mice on d28 after SCI (Student’s t-test; t=22.9; df=5; p=0.01). (F) Staining for myelin by Luxol
(blue), and nuclei by Nissl (pink) both in the absence (w/o; upper panel) or in the presence (lower panel) of DTx (scale bar=250 mm). (G) Quantitative
analysis of the size of the injury site as a function of treatment with DTx, determined by Luxol and Nissl staining. Ablation of infiltrating CD11c
+
monocyte-derived MW resulted in increased lesion size following SCI (Student’s t-test; t=3.6; df=3.82; p=0.02). y-Axis error bar represents SE. The
assessment of the functional outcome is from one experiment, representative of two independent experiments performed.
doi:10.1371/journal.pmed.1000113.g003
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Ly6C
+(Gr1
+)CCR2
+ monocyte subset that can potentially infil-
trate to inflamed tissues [9,50]. Wild-type mice were vaccinated
with the 45D peptide 1 wk before the injury, and then half of the
mice received the MC-21 treatment at d0, d1, d2, d4, and d6
postinjury. The treatment of 45D-immunized C57BL/6 wt mice
with MC-21, which ablated their Ly6C
+ monocytes in the
circulation (Figure 5F), resulted in decreased monocyte recruit-
ment to the lesion site (Figure 5G; 3,0906581 versus 2936108
CD45.1
+/CD11b
+ infiltrating monocyte-derived MW [mean6SE]
without versus with MC-21 treatment, respectively; Student’s t-
test; t=5.6; df=5; p=0.0026), without significantly affecting the
infiltration of other inflammatory cell types (Figure S9). This
treatment abrogated the beneficial effect of the vaccination, as it
resulted in impaired motor function (Figure 5H) and increased
lesion size (Figure 5I) compared to the control group. Collectively,
the data from these two independent depletion experiments
established the critical contribution of monocyte-derived CD11c-
expressing MW in the recovery process following SCI.
To provide further confirmation that the depletion of monocyte-
derived MW was the reason for the impaired recovery following
DTx administration, we examined whether restoration of the
monocyte pool would reverse the functional loss that resulted from
this depletion. We therefore tested whether complementation of the
DTR transgenic monocytes with wt monocytes that do not harbor
the CD11c-DTR transgene, and whose descendants would hence
be resistant to the toxin treatment, could reverse the DTx-induced
loss of recovery. Since we found that the depletion of monocyte-
derived MW starting on the second week and onward did not
impair recovery (Figure S10), we injected the [CD11c-DTR.wt]
BM chimeras with DTx and transferred the resistant Cx3cr1
GFP/+
(CD45.1) monocytes (Figure 6A) in this experiment only during the
time frame of the first week (DTx was injected on d0, d2, d4, and
d7; monocytes were administrated on d0, d3, and d7 post injury).
In this experiment, all animals were vaccinated 1 wk before the
SCI and then divided into three groups; one group was left
untreated and served as a control, and the two others were
subjected to DTx-mediated ablation. One of the DTx-treated
groups received a passive transfer of wt (DTx-resistant) monocytes.
Flow cytometric analysis on d7 revealed the accumulation of graft-
derived MW that expressed CD11c at the lesion area, but not distal
to it (Figure 6B). Immunohistochemical analysis showed the
localization of these cells at the lesion margins; similar to the
endogenous infiltrating myeloid cells, the graft-derived GFP
+ MW
hardly penetrated the epicenter of the lesion site and acquired
distinct morphologies depending on their location (Figure 6C, 6D).
Follow-up of locomotion activity of animals that were similarly
treated revealed that the adoptively transferred wt monocytes
restored the lost functional recovery of DTx-treated [CD11c-
DTR.wt] BM chimeras (Figure 6E). The BMS results correlated
with histological data showing significantly smaller lesions in DTx-
treated mice that had received monocytes, as compared to mice
that received DTx but were not replenished with monocytes
(Figure 6F, 6G). Of note, these results provide further evidence
against a general toxic mechanism as a cause for the functional loss
induced by the depletion procedure.
Macrophages Derived from Infiltrating Monocytes
Display Immunoregulatory Features
To gain insight into the mechanism by which the infiltrating
monocyte-derived MW, located at the margins of the lesion site,
contribute to recovery, we examined whether and how their
ablation affected the level of activated resident microglia.
Interestingly, both the DTx-mediated ablation of monocyte-derived
MW and the depletion of Ly6C
+(Gr1
+) monocytes from the
peripheral blood caused an overall increase in the number of IB-
4
+ cells, indicating enhanced activation of the resident microglia in
the absence of infiltrating monocyte-derived MW (Figure 7A–7C).
Furthermore, transfer of wt monocytes following ablation restored
the regulation of the local immune response, as the numbers of
activated resident microglia were decreased to levels similar to those
found in mice that were not treated with DTx (Figure 7D). These
results suggested that the beneficial effect of the infiltrating
monocyte-derived MW might be due to a regulatory role in
controlling the local inflammation, induced following SCI.
To investigate the factors mediating this regulatory effect, we
tested whether these cells exhibited characteristics associated with
immune-regulating activities [60,61]. Interestingly, analysis of
Figure 4. Vaccination results in enhanced infiltration of monocyte-derived macrophages to the injured spinal cord. [Cx3cr1
GFP/+.wt]
BM chimeric mice were generated by reconstitution of irradiated C57BL/6J mice with bone marrow cells from Cx3cr1
GFP/+-transgenic mice. Half of
these chimeras were vaccinated with myelin-derived altered peptide ligand (45D) 7 d before the SCI. Spinal cord sections were prepared from mice
killed 1, 4, 7, 14, and 21 d after injury. (A) Quantitative analysis of cells labeled with IB-4, to identify both resident microglia and monocyte-derived
MW, at different time points after the contusion, in either vaccinated (gray bar) or unvaccinated (black bar) mice (ANOVA; F9,20=16.7, p=0.0001). (B)
Kinetics of monocyte-derived MW infiltration to the injured site, measured by the number of GFP
+ cells in both vaccinated (gray bar) and
unvaccinated (black bar) mice. Vaccination significantly enhanced the monocyte-derived MW infiltration to the injured site (ANOVA; F9,37=52.12;
p=0.0001). (C) Sections from [Cx3cr1
GFP/+.wt] BM chimeras labeled for GFP (representing infiltrating monocyte-derived MW; green) in unvaccinated
(upper panel) and vaccinated mice (lower panel) (scale bar 250 mm). (D) Quantitative analysis of GFP
+/CD11c
+ cells at the injury site revealing
increased numbers of infiltrating CD11c
+ monocyte-derived MW following vaccination (Student’s t-test; p,0.001). In the kinetic analysis, asterisks
indicate significant differences between vaccinated and unvaccinated groups. Significant differences were also found between different time points.
y-Axis error bar represents SE. The dashed line in (C) that demarcates the lesion site was determined according to GFAP immunoreactivity.
doi:10.1371/journal.pmed.1000113.g004
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located at the margins of the lesion site, but not the distal ones,
expressed arginase-I (Figure 7E, 7F) and the anti-inflammatory
cytokine IL-10 (Figure 7G–7I). Moreover, ablation of CD11c-
expressing monocyte-derived MW resulted in an overall decreased
level of IL-10 at the injury site of [CD11c-DTR.wt] BM chimeras
(Figure S11). Furthermore, adoptively transferred naı ¨ve monocytes
that were injected to the DTx-treated mice, and were shown to
restore recovery, also expressed similar immunoregulatory features
upon encountering the lesion margins (Figure 7J).
Figure 5. Conditional ablation of monocyte-derived macrophages at the injured site or antibody-mediated monocyte-depletion in
the peripheral blood abolishes the augmented recovery in a paradigm of vaccination. (A–E) [CD11c-DTR: Cx3cr1
GFP/+.wt] BM chimeras
were vaccinated 7 d before SCI and divided into two groups; one group was left untreated and one group was injected IP with DTx every other day
starting immediately after the injury. (A) Flow cytometric analysis of lesion sites in injured DTx-treated and non-treated [CD11c-DTR.wt] BM
chimeras. Note specific ablation of CD11c
+ infiltrating monocyte-derived MW in DTx-treated mice, but persistence of CD11c
+ resident microglia
(GFP
2). The cells in the dot plots to the right are gated according to CD11b expression, as indicated. (B) Hind-limb locomotor performance was
assessed according to the BMS (repeated measures ANOVA; F[between groups]1,23=144; p=0.0001). (C) Mean locomotor score (BMS) of individual
mice on d28 after spinal cord injury (Student’s t-test; t=8.6; df=12.21; p,0.0001). (D) Staining for myelin by Luxol (blue), and nuclei by Nissl (pink) in
the absence (w/o; upper panel) or in the presence (lower panel) of DTx (scale bar=250 mm). (E) Quantitative analysis of the size of the injury site as a
function of treatment with DTx, determined by Luxol and Nissl staining. Ablation of infiltrating CD11c
+ monocyte-derived MW resulted in significantly
increased lesion size following SCI (Student’s t-test; t=26.5; df=8; p=0.0002). (F–I) Depletion of Ly6C(Gr1
+)CCR2
+ monocytes in the blood, using MC-
21 antibody (F), resulted in decreased recruitment of infiltrating monocytes to the injured cord (G), worsening of recovery (H; repeated measures
ANOVA; F[between groups]1,11=73.623; p=0.0001), and larger lesion size compared to control group (I; Student’s t-test; t=23.77; df=4.2; p=0.017).
Asterisks denote statistically significant differences between the indicated groups in (C), (E), and (I), and compared to the relevant controls in (B) and
(H). y-Axis error bar represents SE. The assessment of the functional outcome presented is from one experiment representative of four independent
experiments performed.
doi:10.1371/journal.pmed.1000113.g005
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Macrophages to the Recovery Process Is Crucially
Dependent upon Their Expression of IL-10
To investigate the specific contribution of IL-10 to the recovery-
promoting activity of monocyte-derived MW, we compared the
functional recovery of DTx-treated mice that were engrafted with
wt monocytes to that of mice that were engrafted with monocytes
derived from IL-10–deficient mice. [CD11c-DTR.wt] BM
chimeric mice were immunized with 45D and subjected a week
later to SCI. After the injury, the mice were separated into four
groups: one group was left untreated, one group was treated with
DTx, and the other two groups received DTx and a passive
transfer of DTx-resistant monocytes either from wt or from IL-10
deficient mice. The analysis of DTx-treated [CD11c-DTR
(CD45.1).wt (CD45.1)] BM chimeras that had received an
adoptive transfer of CD45.2
+ monocytes (IL-10 deficient or wt)
established that graft-derived IL-10–deficient MW arrived at the
lesion area and expressed CD11c, similarly to their wt counter-
parts (Figure 8A). However, in contrast to the engraftment with wt
monocytes, transfer of IL-10-deficient monocytes failed to restore
recovery, and resulted in similar motor function as that observed
in the DTx-treated mice that did not receive monocytes
(Figure 8B). Moreover, replenishment of IL-10–deficient mono-
cytes did not reduce the lesion size nor restrict the activation of
resident microglia (Figure 8C, 8D). Furthermore, the absence of
IL-10 production by monocytes had no significant effect on the
composition of other inflammatory infiltrates (Figure S12). These
results establish that expression of IL-10 by monocyte-derived MW
is a critical factor determining their ability to control the local
immune response and to contribute to the motor function
recovery.
Discussion
In this study, we demonstrated that a population of MW derived
from infiltrating monocytes located at the margins of the lesion site
contribute to recovery following SCI by mediating an immunoreg-
ulatory role via the anti-inflammatory cytokine IL-10. These cells
are pivotal and nonredundant players in the spontaneous recovery
Figure 6. Replenishment of the monocyte pool restores functional recovery from spinal cord injury. Vaccinated [CD11c-DTR.wt] BM
chimeras were subjected to SCI and subsequently divided into three groups; one group remained untreated and served as a control. The two others
were treated with DTx during the first week after injury with or without replenishment of their monocyte pool with Cx3cr1
GFP/+ monocytes (CD45.1).
(A) Flow cytometric analysis of the naı ¨ve monocyte graft, isolated from the BM, prior to its injection to the injured mice. Note that the vast majority of
cells represent Cx3cr1
GFP/+/CD115
+ monocytes. (B) Flow cytometric analysis of spinal cord samples to identify descendents of grafted monocytes
(CD45.1
+). Note specific homing of transferred monocytes to the lesion area. The dot plot to the right is gated on CD11b
+ MW indicating CD11c
expression on both grafted and endogenous cells. (C) Immunohistological analysis of engrafted cells (GFP
+; green), demonstrating their preferential
localization to the margins of the lesion site demarcated by GFAP (red). (D) Morphological differences between marginal (right) and distal (left)
engrafted cells (GFP
+; green). (E) Mean locomotor score (BMS) for each group as a function of time postinjury. Adoptive transfer of monocytes
resistant to ablation administered in parallel to DTx treatment during the first week restored recovery (repeated measures ANOVA; F[between
groups]2,29=15.97; p=0.0001). (F) Staining for myelin by Luxol (blue), and nuclei by Nissl (pink) of sections taken from DTx-treated mice with or
without adoptive transfer of monocytes. (G) Quantitative analysis of the size of the injury site as a function of monocyte transfer, determined by Luxol
and Nissl staining. Adoptive transfer of monocytes significantly reduced the size of the lesion site compared to the group that was DTx-ablated and
did not receive monocytes (ANOVA; F2,9=42.17, p=0.0001). Asterisks indicate significant differences compared to the relevant controls in (E) and
between the indicated groups in (G). y-Axis error bar represents SE. Scale bar representation: (C) 100 mm; (D) 10 mm; and (F) 200 mm. The dashed line
that demarcates the lesion site was determined according to GFAP immunoreactivity. The assessment of the functional outcome presented is from
one experiment representative of two independent experiments performed.
doi:10.1371/journal.pmed.1000113.g006
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microglia, could not replace their functions. The physiological
recruitment of the monocyte-derived MW to the injured spinal cord
and their essential role in the recovery were demonstrated using a
variety of independent techniques. We found that monocytes
spontaneously infiltrate to the damaged CNS, and that their
descendents preferentially accumulate at the margins of the lesion
site. Augmenting the naı ¨ve monocyte pool by either adoptive
transfer or CNS-specific vaccination resulted in improved recovery.
By using antibody-mediated monocyte depletion in wt mice and
conditional ablation of monocyte-derived MW in BM chimeras
(resulting in the depletion of either naı ¨ve monocytes in the
peripheral blood or their infiltrating descendents at the lesion
margins, respectively), in a manner that spared the resident
microglia, we demonstrated that monocyte-derived MW are pivotal
for recovery. Reconstitution of the monocyte pool by wt monocyte
transfer restored the improvement of motor function, whereas
transfer of IL-10-deficient monocytes failed to do so.
Figure 7. Infiltrating monocyte-derived macrophages exhibit an immunoregulatory phenotype. [CD11c-DTR: Cx3cr1
GFP/+.wt] BM
chimeras were treated and analyzed as follows. (A) Labeling of spinal cord sections with IB-4 (red) to detect the presence of local inflammation, in DTx
untreated (w/o), and treated mice. (B, C) Quantitation of IB-4
+ cells representing local inflammation, in mice treated with DTx along the entire
recovery process, only during the second week, or untreated (B; ANOVA; F2,11=35.69; p=0.0001); or with and without treatment with MC-21 (C;
Student’s t-test; t=24.9; df=8; p=0.001). (D) Quantification of the number of IB-4
+ cells in injured mice, with and without adoptive transfer of DTx-
resistant monocytes given in parallel with the DTx treatment (ANOVA; F2,8=6.1; p=0.025). (E) Arginase I–expressing cells (ARG; red) are restricted to
the margins of the lesion site demarcated by GFAP (green). (F) In [Cx3cr1
GFP/+.wt] BM chimeras, infiltrating monocyte-derived MW (GFP
+; green)
expressed arginase I (ARG; red), arrows indicate double-labeled cells. (G) Interleukin 10 (IL-10; red) expression is confined to the margins of the lesion
site demarcated by GFAP (green). (H) In [Cx3cr1
GFP/+.wt] BM chimeras, monocyte-derived MW (GFP
+; green) expressed IL-10 (red) only in close
proximity to the lesion site. Right panel represents z-axis projection of individual cell. (I) In [CD11c-GFP.wt] BM chimeras, monocyte-derived MW that
expressed CD11c (GFP
+; green) coexpressed IL-10 (red). Right panel represents z-axis projection of individual cell. (J) Graft-derived MW (GFP
+)
expressing interleukin 10 (IL-10; red) at the margins of the lesion site following adoptive transfer to DTx-treated mice. Asterisks denote statistically
significant differences between the indicated groups. y-Axis error bar represents SE. Scale bar in (A) represents 250 mm; in (E), (G), (H), and (I), 100 mm;
in (J), 50 mm; and in (F) and right panels of (H) and (I), 10 mm. The dashed line that demarcates the lesion site was determined according to GFAP
immunoreactivity.
doi:10.1371/journal.pmed.1000113.g007
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chimeras in CNS studies [8,9]; irradiation, even in the absence
of further injury, mobilized monocytes to the noninjured CNS.
Our results are in line with these reports, though the numbers of
these recruited cells were negligible relative to their massive
infiltration following spinal cord injury. Nevertheless, the chimeras
used throughout this study were prepared while shielding their
heads during irradiation, a procedure that prevents any nonspe-
cific infiltration of monocytes and therefore provides a reliable
model for investigating monocyte recruitment following SCI. To
unequivocally prove that this infiltration of monocytes resulted
from the injury and not from the irradiation, we used passive
transfer of naı ¨ve monocytes to nonchimeric wt mice, and
demonstrated, in agreement with other studies [26,62–64], the
spontaneous infiltration of monocytes under CNS pathological
conditions.
Immune cells, and in particular MW/monocytes, have been
recognized as a heterogeneous population in terms of their
functional role, beyond host defense, in the healing of peripheral
organs. However, in the CNS, which is considered an immune-
privileged site, the low levels of spontaneous recovery have been
attributed, at least in part, to a robust and detrimental local
inflammatory response [1,6,7,10].
Our group demonstrated almost a decade ago that alternatively
activated MW promote CNS recovery from injury; specifically, we
showed that peripheral MW activated ex vivo by exposure to
peripheral nerve tissue, when injected at a specific time frame after
the injury to the margins of the lesion site, benefit repair
[22,65,66]. Our finding that such MW are needed for repair was
unexpected, primarily due to the fact that the site of injury is
already laden with microglia/MW, and it was not clear what
further functionality could be provided by the additional cells that
were introduced. At that early stage of our research, it was not
clear whether beneficial MW could be induced only by local
administration of autologous ex vivo–activated MW, or alterna-
tively, whether protective MW are spontaneously recruited as part
of the endogenous repair mechanism, but in numbers that are
insufficient within the critical therapeutic time frame.
The present study highlights the fact that infiltrating monocyte-
derived MW and resident microglia differ in their distribution and
activities following SCI. The resident activated microglia were
distributed throughout the epicenter of the lesion and at its
margins. In contrast, monocyte-derived MW that contributed to
the repair process were largely excluded from the lesion center and
preferentially located at its margins. Selective ablation of
monocyte-derived MW resulted in increased numbers of resident
activated microglia and impaired recovery. Thus, the increased
number of microglia failed to compensate for the loss of infiltrating
monocyte-derived MW, suggesting that these recruited cells have a
unique role in the recovery process that cannot be replaced by the
resident microglia. The distinctive roles of activated microglia and
this subset of monocyte-derived MW may be related to the
activation state of these myeloid cells prior to encountering the
damaged tissue; the resident microglia are embedded in the CNS
prior to the injury and are immediately activated by the insult,
whereas naı ¨ve infiltrating monocyte-derived MW do not encounter
the injured CNS tissue prior to their delayed arrival to the damage
site [67]. Notably, although we followed the recruitment of naı ¨ve
monocytes, our present study is consistent with the previous report
of Rapalino et al. [22], which reported that preactivation of the
transplanted MW is crucial for their beneficial effect; we
demonstrate here that in order to be supportive, the infiltrating
monocyte-derived MW are locally activated to acquire a
nonclassical phenotype, probably en route to the site or within
the local microenvironment of the lesion. Yet, the present study
identifies the beneficial MW as part of the endogenous response to
the insult, and also shows that these nonclassically activated MW
serve an anti-inflammatory role.
Our present results suggest that the recovery following spinal
injury involves monocyte-derived MW, yet these cells, at their
spontaneous levels and activation state, are not sufficient.
Increasing the naı ¨ve-monocyte pool by either adoptive transfer
Figure 8. The contribution of monocyte-derived macrophages to the healing process is crucially dependent upon their expression
of IL-10. [CD11c-DTR (CD45.1).CD45.1] BM mice were vaccinated with 45D, a week later subjected to SCI, and then divided into four groups. One
group remained untreated and served as a control. The three other groups were treated during the first week, with DTx and with or without
administration of DTx-resistant monocytes isolated from either wt or IL-10–deficient mice. (A) Flow cytometric analysis of engrafted wt or IL-10–
deficient (IL-10D) monocytes (CD45.2) found at the lesion area of vaccinated [CD11c-DTR (CD45.1).CD45.1] BM chimeras treated with DTx. The cells
in the dot plots to the right were gated according to CD45.2 expression, as indicated. MW derived from wt and IL-10–deficient monocytes were
located at the lesion area, and expressed CD11c to a similar extent (284.4645.9 versus 301.4610.8 CD11b
+/CD45.2
+ [mean6SE] engrafted IL-10
deficient and wt MW, respectively; Student’s t-test; t=0.36; df=4.4; p=0.73). (B) Mean locomotor score (BMS) for each group as a function of time
post injury (repeated measures ANOVA; F[between groups]3,33=23.4; p=0.0001). (C) Quantitative analysis of the size of the injury site, determined
according to Luxol-Nissl staining, as a function of the IL-10 expression by the transferred monocytes (wt; IL-10D) (ANOVA; F3,29=8.32, p=0.0004). (D)
Quantification of the number of IB-4
+ cells in the lesion area of the different groups (ANOVA; F3,24=21.05; p=0.0001). Asterisks denote statistically
significant differences between the indicated groups in (C) and (D), and compared to the relevant controls in (B). y-Axis error bar represents SE. The
assessment of the functional outcome presented is from one experiment representative of two independent experiments performed.
doi:10.1371/journal.pmed.1000113.g008
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spontaneously recruited cells and improved recovery. This suggests
that at least one of the limiting factors in the beneficial
involvement of innate immune cells following CNS injury is the
availability and/or the extent of the spontaneous recruitment of
monocytes from the circulation. Importantly, although our current
study identifies monocytes as key players in the recovery process,
our findings do not contradict the established contribution of other
immune components [11,13,14,68]. Furthermore, the use of T
cell–based vaccination allowed us to link monocyte involvement in
the recovery process, identified in the current study, with the
beneficial contribution of adaptive immunity that was previously
established by our group [3,69,70]. However, it remains to be
shown how the stimulation of the CNS antigen-reactive T cells in
the vaccination protocol used, contributes to the enhanced
monocyte recruitment, be it via local modifications at the lesion
site or through systemic effects.
Previous studies, which reported enhanced recovery following
depletion of MW, mediated by injection of liposome-encapsulated
clodronate [1] or by blockage of their recruitment using anti-
integrin antibodies [6,7,10,71–73] or chemokine antagonists [74],
suggested that myeloid cells are detrimental to tissue recovery. The
techniques used in those studies resulted in nonselective depletion
or prevented recruitment of all MW/myeloid cells, regardless of
their phenotype, activation, location, and, most importantly,
origin. However, in the present study, we ablated only activated
CD11c expressing monocyte-derived MW, but spared the resident
microglia.
Interestingly, the monocytic infiltrate, whether spontaneous or
enhanced by vaccination, was not detected immediately after
injury. Moreover, ablation of monocyte-derived MW from the
second week onward had no effect on functional recovery. Taken
together, these two observations suggest that the essential effect of
these cells is restricted to the first week following injury, and
probably between d4 and d7 postinjury. Thus, our results do not
refute the potential deleterious effect of other blood-derived cells
or even of other subsets of infiltrating monocytes following SCI,
but rather establish that assuming all MW population to be
destructive at all time points is an inaccurate generalization.
Importantly, our work does not contradict other studies
demonstrating the benefit attained by the restriction of local
inflammation at a certain time point and by a specific
subpopulation of immune cells [6,7,10,75–77]. Our results,
however, attribute a novel anti-inflammatory function to
CD11c
+ monocyte-derived MW, which benefit the injured CNS
by controlling the local immune response, rather than harm it by
adding to the already-detrimental inflammation. Such regulation
depends on timing and location. Thus, our study further
substantiates the notion that while the global suppression of the
immune system denies its potential benefit, a controlled immune
response is pivotal for preventing the spread of damage following
CNS insult.
Histological examination of the SCI lesion sites showed that the
monocyte-derived MW located at the margins of the lesion site
expressed immunoregulatory factors, such as arginase-I and IL-10.
Notably, they share these features with the so-called myeloid-
derived suppressor cells (MDSC) [60,78–81], which were
originally identified in the context of tumor immune escape
mechanisms [78–85], and more recently it has been suggested that
they have a role in non-CNS tissue repair [36,37] and in the
resolution of autoimmune disease of the CNS [34,86]. Important-
ly, our adoptive transfer experiments showed that IL-10-deficient
monocyte-derived MW failed to promote recovery. This estab-
lished that the anti-inflammatory cytokine IL-10, which dictates
MDSC activities outside the CNS [79,87], is a critical factor
determining the beneficial function of the monocyte-derived MW
in CNS recovery. Further studies are needed to establish whether
these infiltrating monocyte-derived MW, identified here as
essential for CNS recovery, are related to the MDSC population.
Interestingly, ablation of the monocyte-derived MW seemed to
affect the resident microglia. Thus, the SCI lesions of DTx-treated
mice displayed a consistently significant increase in IB-4
+ cells in
the histological examinations. Moreover, following this ablation,
flow cytometric analysis showed a higher percentage of activated
CD11c
+ resident microglia at the lesion area. Although further
experiments are required to explore this crosstalk between the MW
infiltrate and the resident microglia, this study argues against the
general assumption that any increased infiltration of immune cells
to the CNS will necessarily lead to enhanced destructive
inflammation, but rather reveals that the infiltrating CD11c
+
MW locally exhibit a phenotype that mediates the down-regulation
of the local immune response. It is possible that other beneficial
properties of infiltrating MW contribute to the repair process; MW
are capable of secreting growth and neurotrophic factors [30–
32,41], phagocytosis and clearance of cell debris [88], degradation
of growth-limiting scar tissue [89], and promotion of remyelina-
tion [32,33,90], all of which may lead to regeneration which is the
most efficient repair process in the CNS.
Altogether, our study brings a new insight into the long-standing
debate regarding the contribution of MW to CNS recovery. We
defined a critical nonredundant role of a unique subset of
infiltrating monocyte-derived MW that, at a specific location and
time frame, mediate their beneficial activity through secretion of
the immunoregulatory cytokine IL-10. This new understanding of
the differential role of activated resident microglia and infiltrating
monocyte-derived MW and their mutual relationship following
CNS insult might enable the development of novel approaches to
manipulate and refine the endogenous repair mechanisms, and
thereby improve currently available therapies for CNS injuries.
Supporting Information
Figure S1 Infiltration of monocytes in head shielded
chimeric mice results from the injury and not from the
irradiation. (A, B) Representative images showing GFP
expression (A) and its quantification (B) in noninjured spinal cord
of [Cx3cr1
GFP/+.wt] BM chimeric mice created with or without
(w/o) head shielding (Scale bar: 250 mm). Results were verified
using flow-cytometric analysis in [CD45.1.wt (CD45.2)] BM
chimeras (132621 versus 867 CD11b
+ [CD45.1] infiltrating
monocyte-derived MW per mg tissue [mean6SE], without and
with head shielding, respectively; Student’s t-test; t=6.19; df=4;
p=0.0035). The GFP or CD45.1 label allowed the identification
of the BM-derived cells and their descendents in the congenic
GFP
2 or CD45.2 recipients. Head protection reduced the massive
infiltration of myeloid cells to noninjured spinal cords (n.d; none
detected). (C) Representative images of infiltrating myeloid cells
(GFP
+) in noninjured and injured spinal cord of [Cx3cr1
GFP/+.wt]
BM chimeric mice prepared with head shielding (Scale bar:
250 mm). (D) Monocyte-derived MW (GFP
+) were found along the
central canal throughout its entire length (Scale bar: 50 mm). (E)
Chimeric [wt.wt] and nonchimeric wt mice were subjected to
SCI and adoptively transferred with CD45.1
+ monocytes
(CD115
+). Quantification of CD11b
+/CD45.1
+ graft-derived cells
based on flow cytometric analysis revealed that the same numbers
of engrafted monocytes infiltrated to the injured spinal cord in
nonchimeric and chimeric mice (Student’s t-test; t=0.21; df=6;
p=0.84). y-Axis error bar represents SE.
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Figure S2 Confirmation of the efficiency of diphtheria
toxin treatment by assessing the spleen. The efficiency of
DTx treatment is routinely verified in the periphery by assessing
depletion of CD11c
+/GFP
+ cells in the spleen of [CD11c-DTR:
Cx3cr1
GFP/+.wt] BM chimeras, in addition to their assessment in
the injured cord.
Found at: doi:10.1371/journal.pmed.1000113.s002 (0.10 MB
TIF)
Figure S3 Monocyte-derived macrophage localization
to the margins of the lesion is independent of the lesion
severity. Immunohistochemical analysis from [Cx3cr1
GFP/+.wt]
BM chimeric mice that were subjected to a moderate contusive
injury of the spinal cord (70 kdynes), showing the restricted
accumulation of the infiltrating monocyte-derived MW (Cx3cr1
GFP/
+; green) at the margins but not at the epicenter of the lesion site,
similar to the distribution of these cells following the severe injury
employed throughout this study. Scale bar=100 mm.
Found at: doi:10.1371/journal.pmed.1000113.s003 (0.15 MB
TIF)
Figure S4 Monocyte-derived myeloid cells do not ex-
press lymphoid or progenitor markers. Representative
flow cytometric plots of various lymphoid/ progenitor markers by
the myeloid infiltrating cells (CD11b
+/ Cx3cr1
GFP/+/CD45.1
+)i n
injured [Cx3cr1
GFP/+ (CD45.1).wt (CD45.2)] BM chimeras
(isotype control, gray line). The percentage of the positive cells
within the infiltrating myeloid population is indicated above each
marker.
Found at: doi:10.1371/journal.pmed.1000113.s004 (0.08 MB
TIF)
Figure S5 Expression of CD11c in the epicenter of the
lesion site from d14 postinjury and onward. Longitudinal
sections labeled for IB-4 (red), GFP (green) and CD11c (yellow),
showing that, at later time points (d14 and onward), CD11c
expression by the resident microglia (IB-4
+/GFP
2 cells) was also
observed at the epicenter of the lesion and not only at its margins.
Right panel shows split images of the left panel. The dashed line
demarcating the lesion site was determined according to GFAP
immunoreactivity. Scale bar=250 mm.
Found at: doi:10.1371/journal.pmed.1000113.s005 (1.49 MB
TIF)
Figure S6 Vaccination with a CNS-specific antigen,
rather than an irrelevant antigen, is required to
augment infiltration of monocyte-derived macrophages
to the injured spinal cord. [CD45.1.wt (CD45.2)] BM
chimeras were vaccinated 7 d prior to spinal cord injury with:
CNS specific antigen (45D/CFA), the irrelevant antigen ovalbu-
min (OVA/CFA), CFA, or PBS alone. The injured spinal cords
were analyzed 1 wk after injury for the entrance of the infiltrating
monocyte-derived MW (CD45.1
+/CD11b
+). Increased infiltration
could be seen only in the mice that were vaccinated with CNS-
specific antigen (ANOVA; F3,9=4.52; p=0.03). Asterisk indicates
significant differences between the indicated group to all other
groups. y-Axis error bar represents SE.
Found at: doi:10.1371/journal.pmed.1000113.s006 (0.02 MB
TIF)
Figure S7 Diphtheria toxin depletes CD11c expressing
monocyte-derived macrophages at the lesion area
without significantly affecting infiltrates of other in-
flammatory cell types. Analysis at the injured site 14 d
postinjury of [CD11c-DTR: Cx3cr1
GFP/+.wt] BM chimeras,
treated without (w/o) or with DTx ablation. (A) Assessment of
monocyte-derived MW; GFP
+ cells, ANOVA; F3,6=21.5;
p=0.0013), and (B, C) of infiltrates of other inflammatory cell
types. Neutrophils were identified by gating on the CD11b
+/
Gr1
high and CD115
2/GFP
2 population, while T cells were
assessed by gating on TCRb
+ cells (Student’s t-test; t=20.5;
df=5; p=0.65 and t=20.04; df=3; p=0.97, respectively). y-Axis
error bar represents SE.
Found at: doi:10.1371/journal.pmed.1000113.s007 (0.12 MB
TIF)
Figure S8 DTx treatment of wt mice that do not harbor
the DTR transgene does not inhibit functional recovery
from spinal cord injury. C57BL/6J mice were subjected to
contusive SCI. Half of the animals were treated with DTx starting
immediately after the injury. Locomotion was recorded at different
time points following the injury, and is presented as the mean
locomotor score (BMS) for each group. DTx administration to the
nonchimeric (C57BL/6J) mice did not affect functional recovery
following SCI (repeated measures ANOVA; F1,18=0.12; p=0.73).
y-Axis error bar represents SE.
Found at: doi:10.1371/journal.pmed.1000113.s008 (0.03 MB
TIF)
Figure S9 MC-21 treatment has no significant effect on
other inflammatory cell types. Quantitative analysis 14 d
postinjury of neutrophils and T cells at the injured site of
[Cx3cr1
GFP/+.wt] BM chimeras, without (w/o) or with MC-21
treatment. Neutrophils were identified by gating on CD11b
+/
Gr1
high and CD115
2/GFP
2 population, while T cells were
assessed by gating on TCRb+ cells (Student’s t-test; t=20.85;
df=5; p=0.43 and t=0.5; df=5; p=0.63, respectively). y-Axis
error bar represents SE.
Found at: doi:10.1371/journal.pmed.1000113.s009 (0.02 MB
TIF)
Figure S10 Ablation of monocyte-derived macrophages
in the second week or at the chronic phase following
spinal cord injury does not affect recovery. (A, B) [CD11c-
DTR: Cx3cr1
GFP/+.wt] BM chimeras were vaccinated with 45D
7 d before SCI, and were treated with DTx during the second
(2
nd) week, along the entire period of recovery, or remained
without DTx treatment. (A) Mean locomotor score (BMS) for each
group as a function of time postinjury, showing that infiltrating
monocyte-derived MW ablation does not affect recovery when it is
carried out during the second week (repeated measures ANOVA;
F[between groups]2,26=16.22; p=0.0001). (B) Quantitative anal-
ysis of the size of the injury site as a function of treatment with
DTx (ANOVA; F2,10=16.34; p=0.007). (C) After verifying that
monocyte-derived MW (GFP
+) expressing CD11c were still found
at the injury site 1 mo after injury, DTx was administered to
immunized and nonimmunized mice DTx by repeated injections
starting from 1 mo postinjury, when the animals had already
reached plateau levels of recovery. The ablation of infiltrating
monocyte-derived MW by DTx application at this late chronic
stage had no effect on locomotor ability. Asterisks denote
statistically significant differences between the indicated groups
in (B) and compared to the relevant controls in (A). y-Axis error
bar represents SE.
Found at: doi:10.1371/journal.pmed.1000113.s010 (0.11 MB
TIF)
Figure S11 Ablation of monocyte-derived macrophages
results in reduction of IL-10 levels in the injured site. (A,
B) The levels of IL-10 at the injury site of [CD11c-DTR:
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GFP/+.wt] BM chimeras that were treated without (w/o) or
with DTx were tested. (A) Representative micrographs of spinal
cord sections labeled for IL-10, in the absence or presence of DTx
treatment (scale bar=100 mm). (B) Quantification of IL-10
+ cells
in the spinal cords with and without DTx treatment, based on
immunohistochemical analysis (Student’s t-test; t=25.33; df=6;
p=0.0018). y-Axis error bar represents SE.
Found at: doi:10.1371/journal.pmed.1000113.s011 (0.34 MB
TIF)
Figure S12 IL-10 deficiency in the infiltrating mono-
cytes has no significant effect on other inflammatory
infiltrates. Quantitative analysis 14 d postinjury of neutrophils
and T cells at the injury site of [CD11c-DTR:Cx3cr1
GFP/+.wt] BM
chimeras treated with DTx in parallel to adoptive transfer of either
wt or IL-10–deficient monocytes. Neutrophils were identified by
gating on the CD11b
+/Gr1
high and CD115
2/GFP
2 population,
while T cells were assessed by gating on TCRb
+ cells (Student’s t-
test; t=2.2; df=4; p=0.11 and t=21.0; df=6; p=0.35,
respectively). y-Axis error bar represents SE.
Found at: doi:10.1371/journal.pmed.1000113.s012 (0.03 MB
TIF)
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Background. Every year, spinal cord injuries paralyze about
11,000 people in the US. The spinal cord, which contains
bundles of nervous system cells called neurons, is the
communication highway between the brain and the body.
Messages from the brain travel down the spinal cord to
control movement, breathing and other bodily functions;
messages from the skin and other sensory organs travel up
the spinal cord to keep the brain informed about the body.
The bones of the spine normally protect the spinal cord but,
if these are broken or displaced, the spinal cord can be cut or
compressed, which interrupts the information flow. Damage
near the top of the spinal cord paralyzes the arms and legs
(tetraplegia); damage lower down paralyzes the legs only
(paraplegia). Spinal cord injuries also cause other medical
problems, including the loss of bladder and bowel control.
Currently, there is no effective treatment for spinal cord
injuries, which usually cause permanent disability because
the damaged nerve fibers rarely regrow.
Why Was This Study Done? After a spinal cord injury,
immune system cells called macrophages accumulate at the
injury site. Some of these macrophages—so-called
monocyte-derived macrophages—come into (infiltrate) the
spinal cord from the blood in response to the injury, whereas
others—microglia—are always in the nervous system.
Although macrophages are essential for wound healing in
other parts of the body, it is unclear whether they have good
or bad effects in the spinal cord. Many experts believe that
immune system cells hinder healing in the spinal cord and
should be suppressed or eliminated, but other scientists
claim that macrophages secrete factors that stimulate nerve
regrowth. Furthermore, although some macrophages
elsewhere in the body have proinflammatory (potentially
deleterious) effects, others have anti-inflammatory
(beneficial) effects. So do the infiltrating monocyte-derived
macrophages and the resident microglia (which are
proinflammatory) have different functions at spinal cord
injury sites? In this study, the researchers try to answer this
important question.
What Did the Researchers Do and Find? The researchers
bruised a small section of the spinal cord of adult mice and
then investigated the effect of infiltrating monocyte-derived
macrophages on the recovery process. Monocyte-derived
macrophages and microglia cannot be distinguished using
standard staining techniques so to study their behavior after
spinal cord injury the researchers introduced labeled
monocyte-derived macrophages into their experimental
animals by using adoptive transfer (injection of genetically
labeled monocytes into the animals) or by making bone
marrow chimeras. In this second technique, the animals’
monocyte-derived macrophages (but not their microglia)
were killed by irradiating the animals before injection of
genetically labeled bone marrow, the source of monocytes.
Using these approaches, the researchers found that
monocyte-derived macrophages collected at the margins
of spinal cord injury sites whereas microglia accumulated
throughout the sites. When the pool of monocyte-derived
macrophages in the mice was increased by adoptive transfer
or by using a technique called ‘‘CNS-specific vaccination,’’
more monocyte-derived macrophages infiltrated the injury
site and the animals’ physical recovery from injury improved.
Conversely, removal of the infiltrating monocyte-derived
macrophages from the injury site reduced the animals’
physical recovery. Other experiments indicated that the
infiltrating monocyte-derived macrophages have a
beneficial, local anti-inflammatory effect that is dependent
on their expression of interleukin-10 (an anti-inflammatory
signaling molecule).
What Do These Findings Mean? These findings provide
new information about the contribution of monocyte-
derived macrophages to spontaneous recovery from spinal
cord injury, a contribution that has long been debated. In
particular, the findings suggest that this subset of
macrophages (but not the resident microglia) has a
beneficial effect on spinal cord injuries that is mediated by
their production of the anti-inflammatory molecule
interleukin-10. The findings also show that the effect of
these monocyte-derived macrophages can be boosted, at
least in mice. Although results obtained in experiments done
in animals do not always accurately reflect what happens in
people, this new understanding of the different functions of
microglia and infiltrating monocyte-derived macrophages
after injury to the spinal cord may eventually lead to the
development of better treatments for spinal cord injuries.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000113.
N The MedlinePlus encyclopedia provides information about
spinal cord injuries (in English and Spanish)
N The US National Institute of Neurological Disorders and
Stroke provides detailed information about spinal cord
injury, including information on current research into the
problem (in English and Spanish)
N MedlinePlus provides an interactive tutorial on spinal cord
injury and a list of links to additional information (in
English and Spanish)
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